NCT02562664View on ClinicalTrials.gov

Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Reproductive EndocrinologyPolycystic Ovarian Syndrome
Interventions
DRUG

CC

100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle

DRUG

Placebo tablets

Placebo tablets taken twice daily continuously for three cycles.

DRUG

Metformin

wMetformin (Cidophage , Amon , Egypt) 500 mg twice daily continuously for three cycles.

All Listed Sponsors
lead

Assiut University

OTHER

NCT02562664 - Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients | Biotech Hunter | Biotech Hunter